- Home
- TENX vs APT Comparison
TENX vs APT Comparison
Compare TENX & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TENX | APT |
|---|---|---|
| Founded | 1967 | 1983 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.2M | 51.4M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | TENX | APT |
|---|---|---|
| Price | $12.82 | $5.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $22.50 | N/A |
| AVG Volume (30 Days) | ★ 294.1K | 47.5K |
| Earning Date | 03-24-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.34 |
| Revenue | N/A | ★ $59,096,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.71 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.63 | $4.06 |
| 52 Week High | $18.38 | $6.20 |
Technical Indicators
Market Signals| Indicator | TENX | APT |
|---|---|---|
| Relative Strength Index (RSI) | 46.69 | 56.49 |
| Support Level | $12.53 | $4.96 |
| Resistance Level | $14.08 | $5.64 |
| Average True Range (ATR) | 0.95 | 0.27 |
| MACD | -0.23 | 0.02 |
| Stochastic Oscillator | 17.74 | 40.58 |
Price Performance
Historical ComparisonAbout TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.